Loading ...

Stock Quote scln

scln Stock Price Today

scln Price History

scln Stock Price History

scln History

Last Price scln

Close Price scln

Day Change scln

After Hours Quote scln

Open Price scln

Day Range scln

Year Range scln

Projected Yield scln

Market Cap scln

Stock Volume scln

Average Volume scln

Forward Price scln

PE for scln

PB for scln

PS for scln

PCF for scln

price earnings ratio scln

price to book ratio scln

price to sales ratio scln

price to cash flow ratio scln

Stock Quote SciClone Pharmaceuticals

SciClone Pharmaceuticals Stock Price today

SciClone Pharmaceuticals Price history

SciClone Pharmaceuticals Stock Price history

SciClone Pharmaceuticals history

Last Price SciClone Pharmaceuticals

Close Price SciClone Pharmaceuticals

Day Change SciClone Pharmaceuticals

After Hours Quote for SciClone Pharmaceuticals

Open Price SciClone Pharmaceuticals

Day Range SciClone Pharmaceuticals

Year Range SciClone Pharmaceuticals

Projected Yield SciClone Pharmaceuticals

Market Cap SciClone Pharmaceuticals

Stock Volume SciClone Pharmaceuticals

Average Volume SciClone Pharmaceuticals

Forward Price SciClone Pharmaceuticals

pe SciClone Pharmaceuticals

pb SciClone Pharmaceuticals

ps SciClone Pharmaceuticals

pcf SciClone Pharmaceuticals

price earnings ratio SciClone Pharmaceuticals

price to book ratio SciClone Pharmaceuticals

price to sales ratio SciClone Pharmaceuticals

price to cash flow ratio SciClone Pharmaceuticals

What Does This Company Do?
SciClone Pharmaceuticals, Inc. is a specialty pharmaceutical company with a substantial commercial business in China and a product portfolio of therapies for oncology, infectious diseases and cardiovascular disorders.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Type
Slow Growth
Employees
570
Stock Style
Small Value

Key Stats  SCLN More...

Key Stats SCLN

S&P 500 index data: S&P 500 Copyright ©

All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .

Sponsor Center

News  scln - SciClone Pharmaceuticals More...

Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days

Analysis  scln - SciClone Pharmaceuticals More...

Free Issue - Morningstar's Dividend Newsletter
More...

An investment is only as good as the cash it returns directly to your pockets. That's why Morningstar DividendInvestor's buy and sell recommendations are driven entirely by dividends. Our total-return strategy gives you carefully selected, picks that combine current income and income growth to generate large, reliable and growing cash returns. Click to try!

More reports scln - SciClone PharmaceuticalsMore...

Click above to view more mutual fund data and stats for scln - SciClone Pharmaceuticals.

  • Performance
  • Asset Allocation
  • Dividend and Capital Gains Distribution
  • News, Alerts and Opinions
  • Video reports
  • Management
  • Filings

Ownership   SCLN More ...

Ownership SCLN

Franklin Biotechnology Discovery A
Vanguard Total Stock Mkt Idx
iShares Nasdaq Biotechnology
QS Batterymarch US Sm Cap Eq I
DFA US Micro Cap I
Stock Price Quote: scln SciClone Pharmaceuticals - XNAS - Morningstar
Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry

Previous: 4119 - Sci Pharmtech Inc  |  Next: scln - SciClone Pharmaceuticals